[HTML][HTML] Hyperuricemia-related diseases and xanthine oxidoreductase (XOR) inhibitors: an overview
C Chen, JM Lü, Q Yao - Medical science monitor: international …, 2016 - ncbi.nlm.nih.gov
Uric acid is the final oxidation product of purine metabolism in humans. Xanthine
oxidoreductase (XOR) catalyzes oxidative hydroxylation of hypoxanthine to xanthine to uric …
oxidoreductase (XOR) catalyzes oxidative hydroxylation of hypoxanthine to xanthine to uric …
HLA association with drug‐induced adverse reactions
Adverse drug reactions (ADRs) remain a common and major problem in healthcare. Severe
cutaneous adverse drug reactions (SCARs), such as Stevens–Johnson syndrome …
cutaneous adverse drug reactions (SCARs), such as Stevens–Johnson syndrome …
Pharmacologic treatment of hypertension in adults aged 60 years or older to higher versus lower blood pressure targets: a clinical practice guideline from the …
A Qaseem, TJ Wilt, R Rich, LL Humphrey… - Annals of internal …, 2017 - acpjournals.org
This article has been corrected. The original version (PDF) is appended to this article as a
Supplement. Description: The American College of Physicians (ACP) and the American …
Supplement. Description: The American College of Physicians (ACP) and the American …
2012 American College of Rheumatology guidelines for management of gout. Part 1: systematic nonpharmacologic and pharmacologic therapeutic approaches to …
D Khanna, JD Fitzgerald, PP Khanna… - Arthritis care & …, 2012 - Wiley Online Library
Gout is a disorder that manifests as a spectrum of clinical and pathologic features built on a
foundation of an excess body burden of uric acid, manifested in part by hyperuricemia …
foundation of an excess body burden of uric acid, manifested in part by hyperuricemia …
Management of acute and recurrent gout: a clinical practice guideline from the American College of Physicians
A Qaseem, RP Harris, MA Forciea… - Annals of internal …, 2017 - acpjournals.org
Description: The American College of Physicians (ACP) developed this guideline to present
the evidence and provide clinical recommendations on the management of gout. Methods …
the evidence and provide clinical recommendations on the management of gout. Methods …
Allopurinol hypersensitivity: investigating the cause and minimizing the risk
LK Stamp, RO Day, J Yun - Nature Reviews Rheumatology, 2016 - nature.com
Allopurinol is the most commonly prescribed urate-lowering therapy for the management of
gout. Serious adverse reactions associated with allopurinol, while rare, are feared owing to …
gout. Serious adverse reactions associated with allopurinol, while rare, are feared owing to …
Allopurinol use and risk of fatal hypersensitivity reactions: a nationwide population-based study in Taiwan
CY Yang, CH Chen, ST Deng, CS Huang… - JAMA internal …, 2015 - jamanetwork.com
Importance Allopurinol, a first-line drug used for treating gout, is increasingly prescribed
worldwide to patients with asymptomatic hyperuricemia and comorbid renal or …
worldwide to patients with asymptomatic hyperuricemia and comorbid renal or …
Controversies in drug allergy: in vitro testing
C Mayorga, DG Ebo, DM Lang, WJ Pichler… - Journal of Allergy and …, 2019 - Elsevier
Despite their low frequency, drug hypersensitivity reactions (DHRs) can be serious and
result in lifelong sequelae. The diagnosis is critical to avert future reactions and should …
result in lifelong sequelae. The diagnosis is critical to avert future reactions and should …
Allopurinol hypersensitivity: a systematic review of all published cases, 1950–2012
SN Ramasamy, CS Korb-Wells, DRW Kannangara… - Drug safety, 2013 - Springer
Background Allopurinol is the primary therapy for the management of chronic gout.
Utilization of allopurinol has increased in tandem with the growing prevalence of gout …
Utilization of allopurinol has increased in tandem with the growing prevalence of gout …
[HTML][HTML] A Comprehensive Review of HLA and Severe Cutaneous Adverse Drug Reactions: Implication for Clinical Pharmacogenomics and Precision Medicine
C Kloypan, N Koomdee, P Satapornpong, T Tempark… - Pharmaceuticals, 2021 - mdpi.com
Human leukocyte antigen (HLA) encoded by the HLA gene is an important modulator for
immune responses and drug hypersensitivity reactions as well. Genetic polymorphisms of …
immune responses and drug hypersensitivity reactions as well. Genetic polymorphisms of …